MGX · Metagenomi Therapeutics, Inc.
Market Cap
$44.95M
Shares
37.78M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2023-01-11 | New | Biotechnology | $99,999,964 | $95,790,739 | 06b |
| 2022-02-07 | New | Biotechnology | $175,374,794 | $175,374,794 | 06b |
| 2021-03-29 | New | Biotechnology | $9,999,995 | $9,999,995 | 06b |
| 2020-11-25 | New | Other Technology | $40,200,000 | $37,544,506 | 06b |
Showing 1–4 of 4 filings
Key facts
CIK
1785279
CUSIP
59102M104
13F (30d)
40 filings
40 filers
Visit website
Investor relations